Trending: Halozyme Drops Bid for Evotec

Dow Jones02:50

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why

Zacks 00:15

Evotec Confirms Review Of Halozyme's Withdrawn EUR 11.00/Share Proposal, Reiterates Confidence In Standalone Growth Strategy

Benzinga00:03

Express News | U.S.-Listed Shares of Evotec Down 19.8% Premarket

BreakingsNov 22 22:14

Sector Update: Health Care Stocks Advance Premarket Friday

MT NewswiresNov 22 22:13

Sector Update: Health Care

MT NewswiresNov 22 21:53